These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 23233360)
1. CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation. Sieger N; Fleischer SJ; Mei HE; Reiter K; Shock A; Burmester GR; Daridon C; Dörner T Arthritis Rheum; 2013 Mar; 65(3):770-9. PubMed ID: 23233360 [TBL] [Abstract][Full Text] [Related]
2. Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells. Chang CH; Wang Y; Gupta P; Goldenberg DM MAbs; 2015; 7(1):199-211. PubMed ID: 25484043 [TBL] [Abstract][Full Text] [Related]
3. Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling. Giltiay NV; Shu GL; Shock A; Clark EA Arthritis Res Ther; 2017 May; 19(1):91. PubMed ID: 28506291 [TBL] [Abstract][Full Text] [Related]
4. Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22. Özgör L; Brandl C; Shock A; Nitschke L Eur J Immunol; 2016 Sep; 46(9):2260-72. PubMed ID: 27352780 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells. Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408 [TBL] [Abstract][Full Text] [Related]
6. CD22 and autoimmune disease. Dörner T; Shock A; Smith KG Int Rev Immunol; 2012 Oct; 31(5):363-78. PubMed ID: 23083346 [TBL] [Abstract][Full Text] [Related]
7. The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Dörner T; Shock A; Goldenberg DM; Lipsky PE Autoimmun Rev; 2015 Dec; 14(12):1079-86. PubMed ID: 26212727 [TBL] [Abstract][Full Text] [Related]
8. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients. Fleischer V; Sieber J; Fleischer SJ; Shock A; Heine G; Daridon C; Dörner T Arthritis Res Ther; 2015 Jul; 17(1):185. PubMed ID: 26183319 [TBL] [Abstract][Full Text] [Related]
9. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation. Fujimoto M; Poe JC; Hasegawa M; Tedder TF J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010 [TBL] [Abstract][Full Text] [Related]
10. Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus. Daridon C; Blassfeld D; Reiter K; Mei HE; Giesecke C; Goldenberg DM; Hansen A; Hostmann A; Frölich D; Dörner T Arthritis Res Ther; 2010; 12(6):R204. PubMed ID: 21050432 [TBL] [Abstract][Full Text] [Related]
11. Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab. Rossi EA; Goldenberg DM; Michel R; Rossi DL; Wallace DJ; Chang CH Blood; 2013 Oct; 122(17):3020-9. PubMed ID: 23821660 [TBL] [Abstract][Full Text] [Related]
12. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen. Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433 [TBL] [Abstract][Full Text] [Related]
13. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts. Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721 [TBL] [Abstract][Full Text] [Related]
14. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22. Bobbitt KR; Justement LB J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914 [TBL] [Abstract][Full Text] [Related]
15. Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells. Chen J; Wang H; Xu WP; Wei SS; Li HJ; Mei YQ; Li YG; Wang YP Oncotarget; 2016 Aug; 7(35):56129-56146. PubMed ID: 27276708 [TBL] [Abstract][Full Text] [Related]
16. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Chan VW; Lowell CA; DeFranco AL Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638 [TBL] [Abstract][Full Text] [Related]
18. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice. Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T Front Immunol; 2018; 9():820. PubMed ID: 29725338 [TBL] [Abstract][Full Text] [Related]
19. SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux. Ostrakhovitch EA; Wang Y; Li SS Cell Signal; 2009 Apr; 21(4):540-50. PubMed ID: 19150402 [TBL] [Abstract][Full Text] [Related]
20. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]